NCT01396785View on ClinicalTrials.gov

Topical Antifungal Treatment for Tinea Pedis

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

March 31, 2012

Conditions
Tinea Pedis
Interventions
DRUG

33525

Daily for 14 days

DRUG

Placebo

Daily for 14 days

Trial Locations (10)

Unknown

Los Angeles

Paramus

Albuquerque

Hershey

Austin

College Station

Plano

San Antonio

Salt Lake City

Cidra

All Listed Sponsors
lead

Medicis Global Service Corporation

INDUSTRY

NCT01396785 - Topical Antifungal Treatment for Tinea Pedis | Biotech Hunter | Biotech Hunter